BX Swiss TOP 30 CHF
1 248,29
|
5,40
|
0,43 %
|
Analysen zu BX Swiss TOP 30 CHF-Werten
09.10.23 | Roche Underweight | JP Morgan Chase & Co. | |
06.10.23 | Richemont Sector Perform | RBC Capital Markets | |
06.10.23 | ABB Neutral | JP Morgan Chase & Co. | |
05.10.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
05.10.23 | Novartis Neutral | JP Morgan Chase & Co. | |
05.10.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
05.10.23 | Novartis Buy | Deutsche Bank AG | |
04.10.23 | Novartis Neutral | UBS AG | |
04.10.23 | Novartis Buy | Deutsche Bank AG | |
04.10.23 | ABB Outperform | RBC Capital Markets | |
03.10.23 | Novartis Buy | Deutsche Bank AG | |
03.10.23 | Nestlé Buy | Deutsche Bank AG | |
03.10.23 | ABB Equal Weight | Barclays Capital | |
03.10.23 | Richemont Buy | UBS AG | |
03.10.23 | ABB Market-Perform | Bernstein Research | |
02.10.23 | UBS Overweight | JP Morgan Chase & Co. | |
02.10.23 | Richemont Sector Perform | RBC Capital Markets | |
29.09.23 | Givaudan Sell | UBS AG | |
29.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
29.09.23 | Givaudan Hold | Deutsche Bank AG | |
29.09.23 | Richemont Overweight | Barclays Capital | |
27.09.23 | UBS Overweight | JP Morgan Chase & Co. | |
27.09.23 | ABB Neutral | JP Morgan Chase & Co. | |
27.09.23 | Givaudan Neutral | JP Morgan Chase & Co. |